Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency.


Journal

The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612

Informations de publication

Date de publication:
05 2022
Historique:
received: 29 07 2021
revised: 15 11 2021
accepted: 11 01 2022
pubmed: 27 2 2022
medline: 18 5 2022
entrez: 26 2 2022
Statut: ppublish

Résumé

Inherited antithrombin deficiency, the most severe form of thrombophilia, is predominantly caused by variants in SERPINC1. Few causal structural variants have been described, usually detected by multiplex ligation-dependent probe amplification or cytogenetic arrays, which only define the gain or loss and the approximate size and location. This study has done a complete dissection of the structural variants affecting SERPINC1 of 39 unrelated patients with antithrombin deficiency using multiplex ligation-dependent probe amplification, comparative genome hybridization array, long-range PCR, and whole genome nanopore sequencing. Structural variants, in all cases only affecting one allele, were deleterious and caused a severe type I deficiency. Most defects were deletions affecting exons of SERPINC1 (82.1%), but the whole cohort was heterogeneous, as tandem duplications, deletion of introns, or retrotransposon insertions were also detected. Their size was also variable, ranging from 193 bp to 8 Mb, and in 54% of the cases involved neighboring genes. All but two structural variants had repetitive elements and/or microhomologies in their breakpoints, suggesting a common mechanism of formation. This study also suggested regions recurrently involved in structural variants causing antithrombin deficiency and found three structural variants with a founder effect: the insertion of a retrotransposon, duplication of exon 6, and a 20-gene deletion. Finally, nanopore sequencing was determined to be the most appropriate method to identify and characterize all structural variants at nucleotide level, independently of their size or type.

Identifiants

pubmed: 35218943
pii: S1525-1578(22)00042-3
doi: 10.1016/j.jmoldx.2022.01.009
pii:
doi:

Substances chimiques

Antithrombins 0
Retroelements 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-475

Informations de copyright

Copyright © 2022 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Belén de la Morena-Barrio (B)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

Christelle Orlando (C)

Department of Haematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Alba Sanchis-Juan (A)

Department of Haematology, University of Cambridge, National Health Service (NHS) Blood and Transplant Centre, Cambridge, United Kingdom; National Institute for Health Research BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Juan L García (JL)

Cancer Research Center (Instituto Universitario de Biología Molecular y Celular del Cáncer) Consejo Superior de Investigaciones Científicas-University of Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica, Department of Hematology, University Hospital of Salamanca, Department of Medicine, University of Salamanca, Salamanca, Spain.

José Padilla (J)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

María E de la Morena-Barrio (ME)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

Marija Puruunen (M)

National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Massachusetts.

Katrien Stouffs (K)

Center for Medical Genetics, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Rosa Cifuentes (R)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

Nina Borràs (N)

Laboratori de Coagulopaties Congènites, Banc de Sang i Teixits, Barcelona, Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Instituto Carlos III, Barcelona, Spain.

Carlos Bravo-Pérez (C)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

Rocio Benito (R)

Cancer Research Center (Instituto Universitario de Biología Molecular y Celular del Cáncer) Consejo Superior de Investigaciones Científicas-University of Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica, Department of Hematology, University Hospital of Salamanca, Department of Medicine, University of Salamanca, Salamanca, Spain.

Javier Cuenca-Guardiola (J)

Departamento de Informática y Sistemas, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria-Arrixaca, Murcia, Spain.

Vicente Vicente (V)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain.

Francisco Vidal (F)

Laboratori de Coagulopaties Congènites, Banc de Sang i Teixits, Barcelona, Medicina Transfusional, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Instituto Carlos III, Barcelona, Spain.

Jesús M Hernández-Rivas (JM)

Cancer Research Center (Instituto Universitario de Biología Molecular y Celular del Cáncer) Consejo Superior de Investigaciones Científicas-University of Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica, Department of Hematology, University Hospital of Salamanca, Department of Medicine, University of Salamanca, Salamanca, Spain.

Willem Ouwehand (W)

Department of Haematology, University of Cambridge, National Health Service (NHS) Blood and Transplant Centre, Cambridge, United Kingdom; National Institute for Health Research BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Kristin Jochmans (K)

Department of Haematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Javier Corral (J)

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, Centro de Investigación Biomédica en Red de Enfermedades Raras, Murcia, Spain. Electronic address: javier.corral@carm.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH